Controlled Substances (Controlled Drugs, Precursors and Plants) (Psilocybine and MDMA) Amendment Regulations 2023 (SA)

South Australia

Controlled Substances (Controlled Drugs, Precursors and Plants) (Psilocybine and MDMA) Amendment Regulations 2023

under the Controlled Substances Act 1984

Contents

Part 1—Preliminary

1            Short title

2            Commencement

Part 2—Amendment of Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014

3            Amendment of Schedule 1—Controlled drugs

4            Amendment of Schedule 3—Controlled plants

Part 1—Preliminary

1—Short title

These regulations may be cited as the Controlled Substances (Controlled Drugs, Precursors and Plants) (Psilocybine and MDMA) Amendment Regulations 2023.

2—Commencement

These regulations come into operation on 1 July 2023.

Part 2—Amendment of Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014

3—Amendment of Schedule 1—Controlled drugs

1. Schedule 1, Part 1, table, item relating to "3,4-Methylenedioxymethyl amphetamine (MDMA)"—after "(MDMA)" insert:

   (except when included in Schedule 8 of the Uniform Poisons Standard)

2. Schedule 1, Part 1, table, item relating to "Psilocybin"—delete the item and substitute the following (such that the amounts specified in the second, third and fourth columns below appear in the table under the headings "Large commercial (mixed)", "Commercial (mixed)" and "Trafficable (mixed)" respectively):

Psilocybine (Psilocybin) (except when included in Schedule 8 of the Uniform Poisons Standard) 1 kg or 100 DDUs 0.25 kg or 20 DDUs 100 g or 10 DDUs

1. Schedule 1, Part 2, table—after the item relating to "Methyldihydromorphine" insert the following (such that the amounts specified in the second, third, fourth, fifth and sixth columns below appear in the table under the headings "Large commercial (pure)", "Large commercial (mixed)", "Commercial (pure)", "Commercial (mixed) and "Trafficable (mixed)" respectively):

3,4-Methylenedioxymethyl amphetamine (MDMA) in preparations for human therapeutic use for the treatment of post-traumatic stress disorder 0.75 kg 1 kg 0.1 kg 0.5 kg 2 g

1. Schedule 1, Part 2, table—after the item relating to "Propiram" insert the following (such that the amounts specified in the second, third and fourth columns below appear in the table under the headings "Large commercial (mixed)", "Commercial (mixed)" and "Trafficable (mixed)" respectively):

Psilocybine (Psilocybin) in preparations for human therapeutic use for the treatment of treatment-resistant depression 1 kg or 100 DDUs 0.25 kg or 20 DDUs 100 g or 10 DDUs

4—Amendment of Schedule 3—Controlled plants

Schedule 3, Part 1, table, item relating to "all fungi that contain PSILOCYBIN"—delete "PSILOCYBIN" and substitute:

PSILOCYBINE (PSILOCYBIN)

Editorial note—

As required by section 10AA(2) of the Legislative Instruments Act 1978, the Minister has certified that, in the Minister's opinion, it is necessary or appropriate that these regulations come into operation as set out in these regulations.

Made by the Governor

on the recommendation of the Controlled Substances Advisory Council and with the advice and consent of the Executive Council

on 29 June 2023

No 63 of 2023